Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPBAR1 | Q8TDU6 | 12/20 | 1.00 |
| ▸ | NR1H4 | Q96RI1 | 6/20 | 1.00 |
| ▸ | SLC10A2 | Q12908 | 3/20 | 1.00 |
| ▸ | ABCC4 | O15439 | 2/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 2/20 | 1.00 |
| ▸ | ENPP2 | Q13822 | 2/20 | 1.00 |
| ▸ | PLA2G1B | P04054 | 1/20 | 1.00 |
| ▸ | SLC10A1 | Q14973 | 6/20 | 0.89 |
| ▸ | VDR | P11473 | 1/20 | 0.79 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Taurochenodeoxycholate SCHEMBL9152921 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2ABCC4ABCB11 | |
| Taurochenodeoxycholate SCHEMBL4411471 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2ABCC4ABCB11 | |
| Taurochenodeoxycholate SCHEMBL13094131 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2ABCC4ABCB11 | |
| Taurochenodeoxycholate SCHEMBL12917602 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2ABCC4ABCB11 | |
| Taurochenodeoxycholate SCHEMBL24001493 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2ABCC4ABCB11 | |
| Taurochenodeoxycholate SCHEMBL40763 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2ABCC4ABCB11 | |
| Taurochenodeoxycholate SCHEMBL24435723 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2ABCC4ABCB11 | |
| Taurochenodeoxycholate SCHEMBL17641266 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2ABCC4ABCB11 | |
| Taurochenodeoxycholate SCHEMBL24015433 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2ABCC4ABCB11 | |
| Taurochenodeoxycholate SCHEMBL17309129 | 1.00 | GPBAR1 (1.00) | GPBAR1NR1H4SLC10A2ABCC4ABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2258 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260139227-A1 | ADIPOSE-DERIVED REGENERATIVE CELL PREPARATIONS | BLUE CELL THERAPEUTICS APS (DK) | 2026-05-21 | — | — | US | claimed |
| CN-122017071-A | Endogenous substance used as biomarker for alcohol-related liver diseases and control application thereof | 中国农业大学 | 2026-05-12 | — | — | CN | claimed |
| CN-122027303-A | Credible cloud security level formalized concept verification system and level assessment method | 武汉可信云科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| EP-4701625-A2 | FORMULATION OF THERAPEUTIC AGENTS FOR IMPROVED PERMEATION | Vivtex Corporation (US) | 2026-03-04 | — | — | EP | claimed |
| EP-4262876-B1 | COVALENTLY MODIFIED ANTIGENS FOR IMPROVED IMMUNE RESPONSE AND/OR STABILITY | DEFENCE THERAPEUTICS INC (CA) | 2026-02-25 | — | — | EP | claimed |
| EP-3350313-B1 | DERIVATION OF LIVER ORGANOIDS FROM HUMAN PLURIPOTENT STEM CELLS | AGENCY FOR SCIENCE TECH AND RESEARCH ASTARSTAR (SG) | 2025-11-26 | — | — | EP | claimed |
| US-12473379-B2 | Method for obtaining purified bacterial polysaccharides | SERUM INSTITUTE OF INDIA PRIVATE LIMITED (IN) | 2025-11-18 | — | — | US | claimed |
| EP-4638478-A1 | COVALENTLY-MODIFIED STEROID ACID-PEPTIDES HAVING ENHANCED STABILITY AND/OR BIOLOGICAL ACTIVITY | Defence Therapeutics Inc. (CA) | 2025-10-29 | — | — | EP | claimed |
| EP-4610652-A1 | YAXAB NANOPORE, NANOPORE SYSTEM COMPRISING SAME AND APPLICATIONS THEREOF | Korea Research Institute of Bioscience and Biotechnology (KR) | 2025-09-03 | — | — | EP | claimed |
| US-12370237-B2 | Lipopeptides for use in treating liver diseases and cardiovascular diseases | RUPRECHT - KARLS - UNIVERSITÄT HEIDELBERG (DE) | 2025-07-29 | — | — | US | claimed |
| US-6040188-A | MEASURING HYDROCARBON CONTAMINANTS IN SOIL BY MIXING SAMPLE WITH MIXTURE OF LIPIDS AND BILE SALTS, FORMING MICELLES; ALLOW SAMPLE-LIPID-BILE SALT MIXTURE COMPOSITION TO SEPARATE INTO LIQUID PHASE AND SOLID PHASE; MEASURE CONTAMINANTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-03-21 | — | — | US | claimed |
| EP-0910411-A1 | HYDROPHOBIC PREPARATIONS CONTAINING MEDIUM CHAIN MONOGLYCERIDES | Cortecs (UK) Limited (GB) | 1999-04-28 | — | — | EP | claimed |
| US-5853974-A | Enhancement of alkaline phosphatase with SDS in chemiluminescent substrates | CHIRON CORPORATION (US) | 1998-12-29 | — | — | US | claimed |
| US-5785989-A | Compositions and methods of manufacturing of oral dissolvable medicaments | UNIVERSITY UTAH RESEARCH FOUNDATION (US) | 1998-07-28 | — | — | US | claimed |
| EP-0832296-A2 | ENHANCEMENT OF ALKALINE PHOSPHATASE WITH SDS IN CHEMILUMINESCENT SUBSTRATES AND ENZYME INHIBITION ASSAYS | CHIRON CORPORATION (US) | 1998-04-01 | — | — | EP | claimed |
| WO-1998000169-A1 | HYDROPHOBIC PREPARATIONS CONTAINING MEDIUM CHAIN MONOGLYCERIDES | CORTECS (UK) LIMITED) (GB) | 1998-01-08 | — | — | WO | claimed |
| WO-1996041015-A9 | ENHANCEMENT OF ALKALINE PHOSPHATASE WITH SDS IN CHEMILUMINESCENT SUBSTRATES AND ENZYME INHIBITION ASSAYS | — | 1997-02-20 | — | — | WO | claimed |
| WO-1996041015-A2 | ENHANCEMENT OF ALKALINE PHOSPHATASE WITH SDS IN CHEMILUMINESCENT SUBSTRATES AND ENZYME INHIBITION ASSAYS | CHIRON CORPORATION (US) | 1996-12-19 | — | — | WO | claimed |
| US-5288498-A | Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 1994-02-22 | — | — | US | claimed |
| US-5288497-A | Compositions of oral dissolvable medicaments | THE UNIVERSITY OF UTAH (US) | 1994-02-22 | — | — | US | claimed |